# Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency

> **NCT02094430** · PHASE2,PHASE3 · COMPLETED · sponsor: **Laboratoire français de Fractionnement et de Biotechnologies** · enrollment: 16 (actual)

## Conditions studied

- Hypofibrinogenemia, Congenital
- Afibrinogenemia, Congenital

## Interventions

- **DRUG:** biological: human fibrinogen concentrate

## Key facts

- **NCT ID:** NCT02094430
- **Lead sponsor:** Laboratoire français de Fractionnement et de Biotechnologies
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2016-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02094430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02094430, "Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT02094430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*